Imipenem is a restricted non-formulary antimicrobial, although it may be used in the case of febrile neutropenia.
Restricted non-formulary drugs consist of those agents that have been reviewed by the Pharmacy and Therapeutics Committee and rejected for addition to the formulary due to lack of demonstrated therapeutic efficacy or safety, unnecessary therapeutic duplication, and/or pharmacoeconomic impact. In addition, one or more therapeutic alternatives exist and are currently on the formulary.
Restricted Non-formulary Drugs are not available via the Non-formulary Request process
The use of non-formulary antimicrobials is strongly discouraged. ASP/ID approval MUST be obtained for ALL non-formulary antimicrobials.